Jacroux Richard 4
4 · ENDRA Life Sciences Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Jacroux Richard
Chief Financial Officer
Transactions
- Award
Common Stock
[F1][F2]2026-03-02+13,461→ 33,461 total
Footnotes (2)
- [F1]Holdings include unvested restricted stock units ("RSUs").
- [F2]Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.
Signature
/s/ Richard Jacroux by Coleman Wombwell, attorney-in-fact|2026-03-04